Results 91 to 100 of about 2,534 (156)

Emerging treatment options for early mycosis fungoides

open access: yesClinical, Cosmetic and Investigational Dermatology, 2013
Montserrat Fernandez-GuarinoDepartment of Dermatology, Hospital Central de la Cruz Roja, Madrid, SpainAbstract: Mycosis fungoides is a candidate for skin-directed therapies in its initial stages. In recent years, therapeutic options outside of the normal
Fernandez-Guarino M
doaj  

Comparative study of calcipotriol (0.005%) ointment and tazarotene (0.05% and 0.1%) gel in the treatment of stable plaque psoriasis [PDF]

open access: yes, 2009
Background: Topical therapies are the first line of treatment for patients with stable plaque psoriasis affecting a limited body surface area. Though in use for more than a decade, we could not find any reports of studies directly comparing calcipotriol
Jain, Rajesh   +3 more
core  

Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis

open access: yesDermatology and Therapy
Introduction An expert panel of Canadian dermatologists was assembled to develop consensus statements regarding the current landscape of topical therapies for plaque psoriasis and the place in therapy of the recently approved fixed-dose combination ...
Lyn Guenther   +6 more
doaj   +1 more source

Linear Darier's disease successfully treated with 0.1% tazarotene gel short-contact therapy.

open access: yes, 2006
We report the case of a 25 year old man affected by linear Darier's disease. The patient presented with brownish keratotic papules involving the trunk in a linear pattern.
AGOZZINO, MANUELA   +5 more
core  

Photocarcinogenesis of topical tazarotene and isotretinoin alone and in combination with valproic acid in hairless mice

open access: yes, 2008
Retinoids and the histone deacetylase inhibitor valproic acid have shown anticancer properties, but the photocarcinogenic or photoprotective effect is unclear. Therefore, we investigated whether a topical formulation of valproic acid is photocarcinogenic
Philipsen, Peter Alshede   +3 more
core  

Home - About - Disclaimer - Privacy